ORALTAG (Interpharma Praha, a.s.)


Welcome to the PulseAid listing for the ORALTAG drug offered from Interpharma Praha, a.s.. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Interpharma Praha, a.s.
NON-PROPRIETARY NAME: Iohexol
SUBSTANCE NAME: IOHEXOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-07-01
END MARKETING DATE: 0000-00-00


ORALTAG HUMAN PRESCRIPTION DRUG Details:

Item DescriptionORALTAG from Interpharma Praha, a.s.
LABELER NAME: Interpharma Praha, a.s.
DEA SCHEDULE:
ACTIVE STRENGTH: 4.5(g/1)
START MARKETING DATE: 2016-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54702-501_c5f8ded2-5fad-407d-bbc9-66af75fafe7b
PRODUCT NDC: 54702-501
APPLICATION NUMBER: NDA205383

Other IOHEXOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GE HealthcareOmnipaque
GE Healthcare Inc.OMNIPAQUE
Interpharma Praha, a.s.ORALTAG